Forbes: In February, the FDA proposed that pharma companies should no longer be required to run endless pages of fine print describing potential side effects of their drugs in direct-to-consumer (DTC) print ads. Anyone who regularly reads newspapers and magazines has seen what the agency is targeting: the reams of confounding, clinically worded caveats that most people need a magnifying glass to read—and an M.D. or Ph.D. to understand.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now